- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis ; volume:32 ; number:6 ; day:20 ; month:6 ; year:2018 ; pages:543-558 ; date:6.2018
CNS drugs ; 32, Heft 6 (20.6.2018), 543-558, 6.2018
- Creator
-
Uitdehaag, Bernard M. J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-018-0530-8
- URN
-
urn:nbn:de:101:1-2018091919441012020231
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Uitdehaag, Bernard M. J.
- SpringerLink (Online service)
Other Objects (12)
Outcome Measures in Clinical Trials for Multiple Sclerosis
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Outcome measures assisting treatment optimization in multiple sclerosis
Drooling outcome measures in paediatric disability: a systematic review
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
The COMET (Core Outcome Measures in Effectiveness Trials) Initiative
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
Registry of Outcome Measures (ROM); tools supporting review and selection of outcome measures (OMs) for studies and trials
Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants
Outcome measures in clinical trials of treatments for acute severe haemorrhage
Systematic review of outcome measures in trials of pediatric anaphylaxis treatment
Systematic review of outcome measures in pediatric eosinophilic esophagitis treatment trials
Outcome Measures in Clinical Trials for Multiple Sclerosis
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Outcome measures assisting treatment optimization in multiple sclerosis
Drooling outcome measures in paediatric disability: a systematic review
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
The COMET (Core Outcome Measures in Effectiveness Trials) Initiative
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
Registry of Outcome Measures (ROM); tools supporting review and selection of outcome measures (OMs) for studies and trials
Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants
Outcome measures in clinical trials of treatments for acute severe haemorrhage
Systematic review of outcome measures in trials of pediatric anaphylaxis treatment
Systematic review of outcome measures in pediatric eosinophilic esophagitis treatment trials
Outcome Measures in Clinical Trials for Multiple Sclerosis
Recurrent disability progression endpoints in multiple sclerosis clinical trials
Outcome measures assisting treatment optimization in multiple sclerosis
Drooling outcome measures in paediatric disability: a systematic review
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials
The COMET (Core Outcome Measures in Effectiveness Trials) Initiative
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
Registry of Outcome Measures (ROM); tools supporting review and selection of outcome measures (OMs) for studies and trials
Relationship between disability and psychiatric outcome in multiple sclerosis patients and its determinants
Outcome measures in clinical trials of treatments for acute severe haemorrhage
Systematic review of outcome measures in trials of pediatric anaphylaxis treatment